Exploring PPARα, β3-adrenergic and Renin/Angiotensin pathways to treat Metabolic dysfunction-Associated Steatotic Liver: A drug repurposing approach.

Authors

Publication Details

Journal
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Published
2025-06-05
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring PPARα, β3-adrenergic and Renin/Angiotensin pathways to treat Metabolic dysfunction-Associated Steatotic Liver: A drug repurposing approach.

Roger Bentanachs Raset
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Liver Disease Diagnosis and Treatment
article

Exploring PPARα, β3-adrenergic and Renin/Angiotensin pathways to treat Metabolic dysfunction-Associated Steatotic Liver: A drug repurposing approach.

Roger Bentanachs Raset
article en

Abstract

No abstract available for this paper.
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Good health and well-being
Openalex Percentile: Top 24%
Liver Disease Diagnosis and Treatment
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Exploring PPARα, β3-adrenergic and Renin/Angiotensin pathways to treat Metabolic dysfunction-Associated Steatotic Liver: A drug repurposing approach. — Roger Bentanachs Raset · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (2025) | TGRS Research Map | TGRS